Mortality of Dandy-Walker syndrome in the United States: Analysis by race, gender, and insurance status

ABSTRACT

Background: Dandy-Walker syndrome (DWS) is a congenital disorder often diagnosed in early childhood. Typically manifesting with signs/symptoms of increased intracranial pressure, DWS is catastrophic unless timely neurosurgical care can be administered via cerebrospinal fluid (CSF) drainage. The rates of mortality, adverse discharge disposition (ADD), and CSF drainage in DWS may not be uniform regardless of race, gender or insurance status; such differences could reflect disparities in access to neurosurgical care. This study examines these issues on a nationwide level. Materials and Methods: The Kids’ Inpatient Database spanning 1997-2003 was used for analysis. Only patients admitted for DWS (ICD-9-CM = 742.3) were included. Multivariate analysis was adjusted for several variables, including patient age, race, sex, admission type, primary payer, income, and hospital volume. Results: More than 14,000 DWS patients were included. Increasing age predicted reduced mortality (OR = 0.87; P < 0.05), ADD (OR = 0.96; P < 0.05), and decreased likelihood of receiving CSF drainage (OR = 0.86; P < 0.0001). Elective admission type predicted reduced mortality (OR = 0.29; P = 0.0008), ADD (OR = 0.68; P < 0.05), and increased CSF drainage (OR = 2.02; P < 0.0001). African-American race (OR = 1.20; P < 0.05) and private insurance (OR = 1.18; P < 0.05) each predicted increased likelihood of receiving CSF drainage, but were not predictors of mortality or ADD. Gender, income, and hospital volume were not significant predictors of DWS outcome. Conclusion: Increasing age and elective admissions each decrease mortality and ADD associated with DWS. African-American race and private insurance status increase access to CSF drainage. These findings contradict previous literature citing African-American race as a risk factor for mortality in DWS, and emphasize the role of private insurance in obtaining access to potentially lifesaving operative care.

Key words

Congenital hydrocephalus - Dandy-Walker syndrome - healthcare disparities - mortality

• References

• 1 Klein O, Pierre-Kahn A, Boddaert N, Parisot D, Brunelle F. Dandy-Walker malformation: Prenatal diagnosis and prognosis. Childs Nerv Syst 2003; 19: 484-9
• 2 Pascual-Castroviejo I, Velez A, Pascual-Pascual SI, Roche MC, Villarejo F. Dandy-Walker malformation: Analysis of 38 cases. Childs Nerv Syst 1991; 7: 88-97
• 3 Hirsch JF, Pierre-Kahn A, Renier D, Sainte-Rose C, Hoppe-Hirsch E. The Dandy-Walker malformation. A review of 40 cases. J Neurosurg 1984; 61: 515-22
• 4 Long A, Moran P, Robson S. Outcome of fetal cerebral posterior fossa anomalies. Prenat Diagn 2006; 26: 707-710
• 5 Forzano F, Mansour S, Ierullo A, Homfray T, Thilaganathan B. Posterior fossa malformation in fetuses: A report of 56 further cases and a review of the literature. Prenat Diagn 2007; 27: 495-501
• 6 Imataka G, Yamanouchi H, Arisaka O. Dandy-Walker syndrome and chromosomal abnormalities. Congenit Anom (Kyoto) 2007; 47: 113-8
• 7 McClelland 3 rd S, Ukwuoma OI, Lunos S, Okuyemi KS. The natural history of Dandy-Walker syndrome in the United States: A population-based analysis. J Neurosci Rural Pract 2015; 6: 23-6
• 8 Salihu HM, Kornosky JL, Druschel CM. Dandy-Walker syndrome, associated anomalies and survival through infancy: A population-based study. Fetal Diagn Ther 2008; 24: 155-60
• 9 Salihu HM, Kornosky JL, Alio AP, Druschel CM. Racial disparities in mortality among infants with Dandy-Walker syndrome. J Natl Med Assoc 2009; 101: 456-61
• 10 Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: An overview. Eff Clin Pract 2002; 5: 143-51